June 21, 2022 Bio/Pharma/CRO Product Launch

Ellutia introduces fully automated total nitrosamine testing for pharmaceuticals at Analytica 2022

Ely, Cambridgeshire, 21st June, 2022: The Ellutia 800 Series Thermal EnergyAnalyser (TEA) has become the industry standard for nitrosamine detection thanks toits selectivity and sensitivity for nitroso compounds. For testing of pharmaceuticaldrugs, the 800 Series TEA can be interfaced to a chemical stripping system thatallows for rapid testing of apparent total nitrosamine content (ATNC). This... Read more

April 5, 2022 Bio/Pharma/CRO Informatics & Software Lab Top-10

Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Optimal Industrial Automation and Technologies, a leader in pharma and biopharma process analytical technology (PAT), pharma manufacturing automation and Quality Assurance (QA) software and systems integration, based in the United Kingdom. The Optimal biopharma tools acquisition strengthens Bruker as a key software and... Read more

April 4, 2022 Acad, Gov/Utilities Bio/Pharma/CRO Informatics & Software PR/Corporate

GE Healthcare Receives FDA Approval of First-Ever Software to Help Automate Anesthesia Delivery and Reduce Greenhouse Gas Emissions During Surgery

CHICAGO – April 4, 2022 – GE Healthcare announced today the FDA pre-market approval (PMA) for its End-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2Anesthesia Delivery System. GE Healthcare is the only manufacturer approved to offer general anesthesia delivery with end-tidal concentration control in the U.S. The company initially released the... Read more

March 23, 2022 Bio/Pharma/CRO Clinical Research/Diagn. Product Launch

GE Healthcare announces first patient dosed in phase III clinical trial for new dopamine transporter imaging radiopharmaceutical

First patient dosed in Phase III clinical trial for PET radiopharmaceutical Next stage clinical study also proceeding for SPECT radiopharmaceutical Both imaging agents aim to assist in the evaluation of adult patients with suspected Parkinsonian syndromes, support research and improve patient care Builds on market leadership with SPECT agent DaTscan™ (Ioflupane I 123 Injection), to... Read more

March 10, 2022 Bio/Pharma/CRO Lab Top-10 Molecular Spectroscopy Product Launch

Announcing New Fourier 80 Benchtop FT-NMR Capabilities for Pharmaceutical and Food Analysis Markets

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announces new capabilities for its benchtop Fourier transform (FT) nuclear magnetic resonance (NMR) spectrometer, the Fourier 80, which does not require special lab infrastructure or cryogens, and offers excellent 1H sensitivity of 200:1 for gradient spectroscopy proton probes. A new adjustable temperature option increases experimental flexibility, while... Read more

February 16, 2022 Bio/Pharma/CRO Environ, Ag./Food & Bev Lab Top-10 PAI Top-10 Product Launch

PerkinElmer’s SIRION Biotech Teams with Centre for Genomic Regulation to Develop New Generation AAV Vectors for Type 1 and Type 2 Diabetes Gene Therapy

Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its SIRION Biotech business, a world leader in viral vector-based gene delivery technologies for gene and cell therapy and vaccine development, and the Centre for Genomic Regulation (CRG), an international... Read more

February 7, 2022 Bio/Pharma/CRO Lab Top-10 Mass Spectrometry Product Launch

Bruker Launches New timsTOF-based MALDI PharmaPulse® Solution for Label-free HTS in Drug Discovery

timsTOF MALDI PharmaPulse® (timsTOF MPP) for Unprecedented High-Throughput Screening (HTS) information content and throughput Innovative timsTOF platform combined with extreme MALDI PharmaPulse speed and robustness for unbiased, deep HTS and uHTS (ultra-high-throughput screening) Trapped Ion Mobility Spectrometry (TIMS): Exploiting ion mobility separation as a new dimension in HTS combined with high resolution QTOF-MS Enabling new... Read more